Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
M.D. Anderson Cancer Center
University of Michigan Rogel Cancer Center
Roswell Park Cancer Institute
University of California, San Francisco
Uppsala University
University of Washington
Minia University
University of Washington
Fudan University
University of Chicago
Rezolute
Rezolute
Institut Paoli-Calmettes
IRCCS San Raffaele
Alliance for Clinical Trials in Oncology
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
UMC Utrecht
European Institute of Oncology
Fudan University
University of Chicago
Qilu Hospital of Shandong University
Universidad Nacional Autonoma de Mexico
AC Camargo Cancer Center
University Medical Center Groningen
University Medical Center Groningen
Huazhong University of Science and Technology
Dana-Farber Cancer Institute
Société Française d'Endoscopie Digestive
Fudan University
Changhai Hospital
European Institute of Oncology
Peking Union Medical College Hospital
University of California, San Francisco
Guangxi Medical University
Uppsala University
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Second Affiliated Hospital, School of Medicine, Zhejiang University
Institut Paoli-Calmettes
Dana-Farber Cancer Institute
IRCCS San Raffaele
University Hospital, Strasbourg, France
M.D. Anderson Cancer Center
Sahlgrenska University Hospital
Dana-Farber Cancer Institute
Singapore General Hospital
HaEmek Medical Center, Israel
Yale University
Stanford University
Maastricht University Medical Center